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1. Introduction 
In the course of the monooxygenase reaction, there 
occurs a binding of substrate to oxidized cytochrome 
P-450 which is often observable in the difference spec- 
trum of the microsomes as a type I spectral change 
[ 1, 21. This is due to a substrate-induced shift in the 
absorbance in the Soret region of oxidized cytochrome 
P-450 from about 420 nm to about 390 nm [3] and is 
accordingly observed as a peak at about 390 nm and a 
trough at about 420 nm in the microsomal difference 
spectrum. Whereas the type I spectral change was early 
associated with metabolism [ 11, there is as yet no 
evidence that the type II spectral change - character- 
ized by a trough near 390 nm and a peak between 
425 and 435 nm in the microsomal difference spectrum 
[ 1, 21 - reflects the formation of a metabolically 
active cytochrome P-450-substrate complex [4], al- 
though some of the basic amines that produce the 
type II spectral change are also substrates of the cyto- 
chrome P-450 containing monooxygenase system. On 
the contrary, the type II spectral change is presumably 
due to ferrihemochrome formation caused by the 
direct interaction between a basic nitrogen and the 
heme iron [ 1,2]. 
One of the characteristics of the cytochrome P-450 
containing monooxygenase system of liver microsomes 
is its apparent lack of substrate specificity. Thus, its 
substrates constitute a chemically and pharmacologically 
quite heterogeneous group, although they seem to share 
one property - a certain degree of lipid solubility. 
Rough correlations have also been reported between 
lipid solubility and metabolism by the cytochrome 
P-450 system for various groups of compounds [5-71. 
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On the other hand, in a recent study on the interaction 
of a series of barbiturates with cytochrome P-450, it 
was concluded that although lipid solubility is required 
for a substance to reach microsomal cytochrome 
P-450, other properties of the molecule are of im- 
portance for determining the affinity with which it 
will interact with the cytochrome [8]. 
In the present study, the (t) and (-) isomers of 
amphetamine and four N-substituted amphetamine 
derivatives have been used to further characterize sub- 
strate properties of importance for the interaction with 
cytochrome P-450. The results support the above con- 
clusion that lipid solubility is of minor importance for 
deciding the affinity by which such interaction takes 
place and clearly indicate stereoselectivity in cyto- 
chrome P-450-substrate interaction. 
2. Materials and methods 
Unstarved, male rabbits (local strain) weighing 
1.5-2.0 kg were used. Animals were sacrificed by a 
blow on the head and bleeding. The liver was immedi- 
ately removed, placed in ice-cold 0.25 M sucrose, cut 
into small pieces and homogenized in 4 vol of 0.25 M 
sucrose. After sedimentation of cell debris, nuclei and 
mitochondria by centrifugation at 13,300 g for 10 min, 
the microsomal fraction was pelleted by centrifugation 
at 105,000 g for 60 min. The microsomal pellets were 
washed once with 0.15 M KCl, resedimented by centri- 
fugation at 105,000 g for 30 min and suspended in 
0.25 M sucrose at a protein concentration of about 
10 mg per ml. Protein concentrations were determined 
by the method of Lowry et al. [9]. 
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The spectral changes caused by addition of various 
substrates to a suspension of microsomes were recorded 
in an Aminco-Chance dual wavelength/split beam 
recording spectrophotometer. Each cuvette .contained 
a microsomal suspension (5 mg microsomal protein/ml) 
in 50 mM Tris-HCl-15 mM KC1 medium, pH 7.5. The 
substrates were added to the sample cuvette and 
equivalent amounts of the solvent were added to the 
reference cuvette. K, and AA,,,, values were deter- 
mined according to Schenkman [2]. 
The lipid solubility of the compounds were deter- 
mined in a system containing corn oil and 0.5 M 
potassium phosphate buffer, pH 7.5. The compounds 
were shaken 1 hr in the oil-buffer system. The con- 
centration of the compounds in the water phase was 
determined by comparison of the absorption peaks in 
the 250-260 nm region. 
3. Results 
Axelrod early showed that liver microsomes catalyze 
the conversion of amphetamine to phenylacetone in 
the presence of NADPH and molecular oxygen [lo]. 
Gillette et al. [ 1 l] subsequently reported that the 
metabolism of amphetamine is inhibited by carbon 
monoxide, indicating the involvement of cytochrome 
P-450 in the reaction. Further evidence for such in- 
volvement was obtained in the present study. 
As shown in fig. 1, the addition of (+) amphetamine 
at a low concentration to a suspension of rabbit liver 
microsomes, gave rise to a type I spectral change. When 
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Fig. 1. Difference spectra upon addition of (+) amphetamine 
to rabbit liver microsomes. (--_) 117 PM; (----I 1.5 mM; 
(G-.) 7.5 mM (+) amphetamine. 
Fig. 2. Determination of the spectral dissociation constant 
(K,) of (-1 amphetamine. Double reciprocal plots of the 
absorbance changes at 420 nm and 490 nm recorded upon 
addition of increasing concentrations of (6) amphetamine to 
a suspension of rabbit liver microsomes. 
the amphetamine concentration was increased, how- 
ever, this gradually turned into a type II spectral change, 
indicative of ferrihemochrome formation. It thus 
seems obvious that both (t) and (-) amphetamine 
can interact with cytochrome P-450 at two different 
sites; a high-affinity site to produce the type I spectral 
change (KS values of 12 PM and 8 FM, respectively 
(fig. 2 and table l)), and a low-affinity site to produce 
the type 11 spectral change (KS values of approx. 
4.5 mM and 0.5 mM, respectively (not documented)). 
As expected, we found amphetamine metabolism to 
be optimal at concentrations giving rise to the type I 
spectral change. A comparison of the apparent K, 
values for(t) and (-) amphetamine and the apparent 
Table 1 
Dissociation constants for the cytochrome P-450Gsubstrate 
complex 
_ 
(+) (-) 
K, CUM) K, (FM) 
Amphetamine 12 8.0 
Methylamphetamine 7.2 6.4 
Ethylamphetamine 0.080 9.1 
Isopropylamphetamine 0.53 7.2 
Dimethylamphetamine IO 8.3 
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Table 2 4. Discussion 
Lipid solubility of amphetamine and some amphetamine deri- 
vatives. 
% in oil phase 
t+1 (-I 
Amphetamine 6 6 
Methylamphetamine 5 5 
Ethylamphetamine 11 11 
Isopropylamphetamine 19 20 
Dimethylamphetamine 28 28 
Corn oil-O.5 M phosphate buffer pH 7.4. 
Michaelis constants, estimated from the formation of 
phenylacetone, gave the following results: (t) amphet- 
amine, KS = 12 PM and K, = 7 PM and (-) amphet- 
amine, KS = 8 PM and K, = 6 PM. 
This study has provided further evidence that 
basic amines, which can serve as substrates for cyto- 
chrome P-450, can interact with the hemoprotein to 
produce the type I spectral change. Such interaction 
is usually observed at low drug concentrations which, 
however, seem to be optimal for metabolism. As pre- 
viously observed with didemethyl-imipramine [ 121, 
we found the type I spectral interaction to be over- 
shadowed by a type II spectral change upon increase 
in drug concentration. A type II spectral change has 
previously been observed by Fouts et al. upon addi- 
tion of amphetamine at a high concentration to liver 
microsomes [ 131. These findings are in accordance 
with the hypothesis that “type I interaction” is of 
importance for metabolism [4]. 
Both isomers of the N-substituted amphetamine 
derivatives gave rise to the type I spectral change in all 
concentrations investigated. Furthermore, in spite of 
considerable differences in lipid solubility (table 2) 
they appeared to interact with similar amounts of the 
cytochrome P-450 present, as judged from the magni- 
tude of the type I spectral change (table 3). The (-) 
isomers exhibited similar affinities for this interaction, 
whereas the (t) isomers displayed considerable differ- 
ences in affinity (table l), which were, however, not 
strictly correlated to differences in lipid solubility 
(cf. tables 1 and 2). Strong evidence for stereoselec- 
tivity in cytochrome P-450-substrate interaction was 
obtained with ethyl- and isopropylamphetamine, whose 
two isomers displayed marked differences in apparent 
KS values (table 1). 
Since the magnitude of the type I spectral change 
obtained at saturating substrate concentration is pro- 
portional to the amount of cytochrome P-450 present 
[ 11, it seems that the N-substituted amphetamine 
derivatives investigated can react with equal amounts 
of cytochrome P-450, in spite of considerable differ- 
ences in lipid solubility. This is in contrast to recent 
findings with a series of barbiturates which, at satura- 
ting concentrations, produced different magnitudes 
of the type I spectral change which showed some 
correlation with the lipid solubility of the compounds 
[8]. Whether also amphetamine can interact with the 
same concentration of cytochrome P-450 as the 
N-substituted derivatives, could not be decided 
because of the change in the type of spectral interac- 
tion that occurred upon increase in concentration of 
this drug. 
Table 3 
Spectral interactions of some amphetamine derivatives with 
rabbit liver microsomes. 
(+I (-1 
___-- 
AA 
nmole P-450 
AA 
-- 
nmole P-450 
Amphetamine 
Methylamphetamine 
Ethylamphetamine 
Isopropylamphetamine 
Dimethylamphetamine 
_ _ 
0.028 0.026 
0.023 0.028 
0.026 0.028 
0.023 0.028 
No apparent differences in binding affinity were 
found with the (-) isomers of the investigated am- 
phetamine derivatives in spite of considerable differ- 
ences in lipid solubility. This observation supports the 
previous conclusion that other properties besides lipid 
solubility govern the affinity by which substrates in- 
teract with cytochrome P-450 [8]. This point is 
further strengthened by the considerable differences 
in KS values obtained with the (t) and (-) isomers of 
ethyl- and isopropylamphetamine, which, in agreement 
with a previous observation [ 141, clearly indicates 
stereoselectivity in cytochrome P-450-substrate inter- 
action. 
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